2017
DOI: 10.1016/j.jval.2017.08.1429
|View full text |Cite
|
Sign up to set email alerts
|

Analyzing the Treatment Cost of Liver Cirrhosis from Healthcare Payer’s Perspective of Vietnam in 2015

Abstract: A633 cost, drugs cost accounted for the highest proportion with 44.52%; the lower is the clinical test cost with 21.67% (3,376,153.70 and 1,643,644.83 VND; respectively). The influential factors on costs of treatment included the place of residence, the number of days in hospital, the stage and the complications of cirrhosis. ConClusions: With the rising trend of liver cirrhosis in Vietnam and the high cost of treatment, national health policies and medical programs should be considered.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 0 publications
1
2
0
Order By: Relevance
“…In a study of patients with cirrhosis in Vietnem, Nguyen et 39 of which almost 69% of the costs were covered by health insurance. 20 Although comparisons between our estimates and those provided by the studies cited above need to be made with caution because of our small sample, variations in the disease stage, exact types and duration of treatment provided (among other variables), our findings confirm that irrespective of the setting, the amount expended to treat each of the diseases considered is significant. Boutayeb and Boutayeb in their review of the burden of NCDs in low-income and middle-income countries highlighted the huge difference in costs expended in managing NCDs between patients in developed and low-income and middle-income countries and between affluent and poor patients within developed countries noting that this reflected inequity in access to treatment.…”
Section: Medical Costs Of Lung Cancersupporting
confidence: 68%
See 2 more Smart Citations
“…In a study of patients with cirrhosis in Vietnem, Nguyen et 39 of which almost 69% of the costs were covered by health insurance. 20 Although comparisons between our estimates and those provided by the studies cited above need to be made with caution because of our small sample, variations in the disease stage, exact types and duration of treatment provided (among other variables), our findings confirm that irrespective of the setting, the amount expended to treat each of the diseases considered is significant. Boutayeb and Boutayeb in their review of the burden of NCDs in low-income and middle-income countries highlighted the huge difference in costs expended in managing NCDs between patients in developed and low-income and middle-income countries and between affluent and poor patients within developed countries noting that this reflected inequity in access to treatment.…”
Section: Medical Costs Of Lung Cancersupporting
confidence: 68%
“…In a study of patients with cirrhosis in Vietnem, Nguyen et al estimated that the median cost of treatment per session in 2015 was VND7 439 527.40±VND52 514 030.97, that is, approximately US$329.90±US$232.88 (US$1 in VND:US$22 550.18 for 31 December 2015) 39 of which almost 69% of the costs were covered by health insurance. 20 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation